市場調查報告書
商品編碼
1500601
手術縫線市場:按類型、材料、應用和最終用戶分類 - 全球預測 2024-2030Surgical Suture Market by Type (Monofilament Sutures, Multifilament Sutures), Material (Absorbable, Non-Absorbable), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年手術縫線市場規模為48億美元,預計2024年將達50.8億美元,2030年將達70.7億美元,複合年成長率為5.67%。
手術縫合線是在癒合過程中連接傷口或切口附近皮膚邊緣的醫療設備。縫合線通常用於各種外科手術,包括內傷和外傷。手術縫合線由多種材料製成,包括天然材料(絲綢和腸線)、合成材料(尼龍和聚丙烯)和可吸收材料(Polyglycolic和聚乳酸)。為了最佳化傷口縫合併促進正確癒合,可以採用多種模式進行縫合,包括簡單間斷縫合、連續縫合和褥式縫合。此外,老年人經常需要針對各種醫療狀況進行手術干預,包括關節關節重建、心血管手術和癌症治療,這增加了對手術縫合的需求。然而,用於手術縫合的多種替代創傷護理管理產品和頻繁的破損問題阻礙了它們的使用。此外,材料科學和技術的進步導致了性能改進的新型縫合材料的開發。
主要市場統計 | |
---|---|
基準年[2023] | 48億美元 |
預計年份 [2024] | 50.8億美元 |
預測年份 [2030] | 70.7億美元 |
複合年成長率(%) | 5.67% |
區域洞察
由於醫療保健行業完善、外科手術數量不斷增加以及先進醫療技術的高採用率,美洲的手術縫線市場正在成長。該市場的整容手術正在興起,刺激了對手術縫合線的需求。醫療保健產業的進步、人口老化的加劇以及對高品質和可靠產品的強烈偏好導致歐洲、中東和非洲地區對手術縫合線的需求增加。在醫院和診所的增加以及政府對醫療基礎設施現代化的努力的推動下,中東和非洲的手術縫合線市場正在穩步成長。醫療基礎設施的不斷改善、龐大的人口基數以及對開發新材料和技術的日益關注正在影響亞太地區手術縫線市場的成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在手術縫線市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對手術縫線市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在手術縫合線市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[182 Pages Report] The Surgical Suture Market size was estimated at USD 4.80 billion in 2023 and expected to reach USD 5.08 billion in 2024, at a CAGR 5.67% to reach USD 7.07 billion by 2030.
Surgical sutures are medical devices that hold together the edges of skin near the wound or incision during the healing process. They are commonly employed in various surgical procedures, including internal and external wounds. Surgical sutures are made of multiple materials, including natural substances (silk or catgut), synthetic materials (nylon or polypropylene), or absorbable materials (polyglycolic acid or polylactic acid). Sutures can be placed in different patterns, such as simple interrupted, continuous, or mattress sutures, to achieve optimal wound closure and promote proper healing. Moreover, older adults often require more surgical interventions for various medical conditions, including joint replacements, cardiovascular surgeries, and cancer treatments, increasing the need for surgical sutures. However, various alternative wound care management products and frequent breakage problems in surgical sutures impede their use. Additionally, material science and technology advances have led to the development of new suture materials with improved properties.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.80 billion |
Estimated Year [2024] | USD 5.08 billion |
Forecast Year [2030] | USD 7.07 billion |
CAGR (%) | 5.67% |
Regional Insights
The surgical sutures market is growing in the Americas owing to the well-established healthcare sector, increased surgical procedures, and a high adoption rate of advanced medical technologies. The market is witnessing a growth in aesthetic and cosmetic surgeries, fueling the need for surgical sutures. Advancements in the healthcare sector, coupled with an increasing aging population and strong preference for high-quality and reliable products, are resulting in an increased need for surgical sutures in the EMEA region. The Middle East and Africa's surgical sutures market is growing steadily, driven by the increasing number of hospitals and clinics and government initiatives to modernize healthcare infrastructure. Continuous improvements in healthcare infrastructure, a large population base, and a growing emphasis on developing novel surgical suture materials and techniques are influencing the growth of the surgical sutures market in the APAC region.
Market Insights
The market dynamics represent an ever-changing landscape of the Surgical Suture Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Surgical Suture Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Surgical Suture Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Suturion and Healthcare 21 Sign Exclusive Distributor Agreement
Suturion has entered into an exclusive distribution agreement with Healthcare 21, an eminent innovative healthcare solutions provider. This agreement is anticipated to leverage Healthcare 21's robust distribution network to heighten the accessibility and availability of Suturion's advanced suture technology to healthcare professionals across the United Kingdom. [Published On: 2023-10-17]
Genesis MedTech secures China's NMPA Approval for Absorbable Sutures
Genesis MedTech Group achieved a milestone with the National Medical Products Administration's (NMPA) authorization of its novel absorbable surgical sutures. This innovative product, engineered to dissolve within the body over time, promises to enhance the standard of surgical care in the region by reducing the necessity for follow-up procedures to remove sutures, thus contributing to improved patient recovery experiences. [Published On: 2023-09-12]
Riverpoint Medical Invests USD 10 Million In Its New Facilities And Manufacturing Site In The Coyol Free Trade Zone
Riverpoint Medical expanded its operational footprint with a significant USD 10 million investment in a new facility in Costa Rica's Coyol Free Trade Zone. This substantial financial commitment underscores the company's dedication to growth and its intent to optimize production efficiencies and elevate product quality. The new site is poised to bolster the company's manufacturing capabilities, particularly in producing surgical sutures, a critical segment in the medical supply industry. [Published On: 2023-08-22]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Surgical Suture Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Surgical Suture Market, highlighting leading vendors and their innovative profiles. These include Able Medical Devices Inc., AD Surgical, Advanced Medical Solutions Group plc, AIP Medical SA, Atramat by Internacional Farmaceutica S.A . de C.V., B. Braun SE, Centenial Surgical Suture Ltd., CONMED Corporation, Corza Medical GmbH, DemeTECH Corporation, Demophorius Healthcare Ltd., Dolphin Sutures, Genesis Medtech, GMD Group, Healthium Medtech Ltd., Johnson & Johnson Services, Inc., Lotus Surgicals Pvt Ltd, Lux Sutures SA, Lydus Medical, McKesson Medical-Surgical Inc., Medtronic PLC, Mellon Medical B.V., Orion Sutures India Pvt Ltd, Peters Surgical, Riverpoint Medical, Shandong Haidike Medical Products Co.,Ltd., Smith & Nephew PLC, Stryker Corporation, Sutumed Corp., SUTUREGARD Medical, Inc., Teleflex Incorporated, Unisur Lifecare Pvt. Ltd., Vitrex Medical A/S, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage